Evidence map›Paper›PMID 40850682›Full record

ArticleJournal of advanced research2026

Long noncoding RNA Nron and its functional motif modulate macrophage-mediated inflammatory response.

Liuye Yang, Pengchao Wang, Kaiyuan Liu, Bing Liu, Jingbo Zhu, Fengcen Li, Mingfa Ai, Xiaoguang Li, Minglu Liang, Kai Huang and 1 more

Abstract read
In one paragraph

Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liuye YangDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pengchao WangDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kaiyuan LiuXiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Bing LiuThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jingbo ZhuDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fengcen LiDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Mingfa AiDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaoguang LiHubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology, Wuhan, China; Hubei Clinical Research Center of Metabolic and Cardiovascular Disease, Huazhong University of Science and Technology, Wuhan, China.
Minglu LiangHubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology, Wuhan, China; Hubei Clinical Research Center of Metabolic and Cardiovascular Disease, Huazhong University of Science and Technology, Wuhan, China.
Kai HuangHubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology, Wuhan, China; Hubei Clinical Research Center of Metabolic and Cardiovascular Disease, Huazhong University of Science and Technology, Wuhan, China. Electronic address: huangkai1@hust.edu.cn.
Meng DuHubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology, Wuhan, China; Hubei Clinical Research Center of Metabolic and Cardiovascular Disease, Huazhong University of Science and Technology, Wuhan, China; Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: D201378184@alumni.hust.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNon-resolving macrophage-mediated inflammation is closely linked to the pathogenesis of systemic inflammatory response syndrome. Despite years of clinical trials attempting to mitigate the harmful effects of excessive inflammation, these efforts have largely been unsuccessful. Therefore, it is essential to develop novel therapeutic strategies.

objectiveTo explore the role of Nron in inflammatory diseases and evaluate the therapeutic effect.

methodsConditional knockout/knockin mice were used for a systematic evaluation of Nron function in lipopolysaccharide (LPS) or cecal ligation and puncture (CLP)-induced sepsis. Quantitative real-time PCR, western blot, luciferase reporter assay, and RNA-RNA interaction assay were performed to investigate mechanisms and identify functional motifs. An enhanced lipid nanoparticle (LNP) formulation was constructed for targeted macrophage delivery and therapy. Moreover, monocytes were obtained from blood of patients with sepsis for in vitro culture, and the serum for enzyme-linked immunosorbent assay (ELISA) detection. Data analysis was conducted using GraphPad Prism 8.

resultsConditional knockout of Nron in myeloid cells exacerbates LPS or CLP-induced sepsis, while the conditional transgenic mice exhibited a survival advantage with alleviated tissue inflammation and damage. Nron enhances sirtuin 1 (SIRT1) deacetylase activity via sponging miR-146a-3p/miR-16-1-3p in macrophages, thus regulating on nuclear factor kappa B (NF-κB) signaling by inhibiting p65 acetylation/phosphorylation directly or via HIF-1 signaling. The conserved functional motif of Nron (NCM2) has a longer half-life and LNP-NCM2 targeted to macrophages effectively alleviated sepsis in mice.

conclusionNron serves as a crucial negative regulator of excessive inflammatory responses, and its functional motifs can be used as a potential therapeutic agent for inflammatory diseases such as sepsis.

Indexed as

RNA, Long NoncodingSystemic Inflammatory Response SyndromeAnimalsCase-Control StudiesCell Line, TumorHumansMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutNF-kappa BSepsisSirtuin 1NF-kappa BNRON long noncoding RNA, humanNRON long non-coding RNA, mouseRNA, Long NoncodingSirtuin 1InflammationLncRNANucleic acid therapySepsis

Identifiers

PMID40850682
PMCPMC13131433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.